| scholarly article | Q13442814 |
| P50 | author | David Warrilow | Q90037940 |
| Richard Allcock | Q115217601 | ||
| P2093 | author name string | Amy V Jennison | |
| P2860 | cites work | Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. | Q23047571 |
| Real-time, portable genome sequencing for Ebola surveillance | Q24283957 | ||
| Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates | Q24669589 | ||
| Standardization and quality management in next-generation sequencing | Q28077041 | ||
| The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis | Q28608163 | ||
| Fast and sensitive protein alignment using DIAMOND | Q29011988 | ||
| Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. | Q30145570 | ||
| Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring | Q30427798 | ||
| Diverse and widespread contamination evident in the unmapped depths of high throughput sequencing data | Q30865295 | ||
| Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples | Q33603869 | ||
| To disclose, or not to disclose? Context matters | Q33774038 | ||
| Amplification methods bias metagenomic libraries of uncultured single-stranded and double-stranded DNA viruses | Q34021610 | ||
| Actionable diagnosis of neuroleptospirosis by next-generation sequencing | Q34053612 | ||
| Whole-genome sequencing to control antimicrobial resistance | Q34142073 | ||
| A first look at the Oxford Nanopore MinION sequencer | Q34436807 | ||
| The evolution of nanopore sequencing | Q34459110 | ||
| Microbial contamination in next generation sequencing: implications for sequence-based analysis of clinical samples | Q34550120 | ||
| The origin of biased sequence depth in sequence-independent nucleic acid amplification and optimization for efficient massive parallel sequencing | Q35006219 | ||
| Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent | Q35132373 | ||
| Beyond research: a primer for considerations on using viral metagenomics in the field and clinic | Q35216170 | ||
| From benchtop to desktop: important considerations when designing amplicon sequencing workflows | Q35527797 | ||
| Nanopore-based fourth-generation DNA sequencing technology | Q35543895 | ||
| Reporting Incidental Findings in Genomic Scale Clinical Sequencing-A Clinical Laboratory Perspective: A Report of the Association for Molecular Pathology | Q35561832 | ||
| Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples. | Q35757609 | ||
| Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing | Q36371768 | ||
| Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis | Q36373327 | ||
| Direct next-generation sequencing of virus-human mixed samples without pretreatment is favorable to recover virus genome. | Q36454627 | ||
| Towards a European consensus for reporting incidental findings during clinical NGS testing | Q36695676 | ||
| Unbiased Detection of Respiratory Viruses by Use of RNA Sequencing-Based Metagenomics: a Systematic Comparison to a Commercial PCR Panel | Q36734877 | ||
| Managing the ethical challenges of next-generation sequencing in genomic medicine | Q38239811 | ||
| Next generation sequencing: considering the ethics | Q38262805 | ||
| Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples | Q38284965 | ||
| MinION Analysis and Reference Consortium: Phase 2 data release and analysis of R9.0 chemistry. | Q38631400 | ||
| Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection | Q38974462 | ||
| Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing. | Q39352653 | ||
| Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing. | Q40758663 | ||
| Multiple displacement amplification compromises quantitative analysis of metagenomes | Q57119754 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3175-3182 | |
| P577 | publication date | 2017-08-23 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Towards a universal molecular microbiological test | |
| P478 | volume | 55 |
| Q89899486 | Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies |
| Q92068216 | Diagnostic value and clinical application of next-generation sequencing for infections in immunosuppressed patients with corticosteroid therapy |
| Q63246232 | Illumina sequencing of clinical samples for virus detection in a public health laboratory |
| Q64994379 | Lowering the Barriers to Routine Whole-Genome Sequencing of Bacteria in the Clinical Microbiology Laboratory. |
| Q58564757 | Metagenomics for investigation of an unusual meningococcal outbreak |
| Q64096090 | Rapid identification and phylogenetic classification of diverse bacterial pathogens in a multiplexed hybridization assay targeting ribosomal RNA |
| Q90520706 | Shotgun Metagenomic Detection of Pathogens: a Micro-Comic Strip |
Search more.